3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
von Hippel-Lindau Disease
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lung Neoplasms
1
Kidney Neoplasms
1
Hodgkin Disease
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Medullary
1
Breast Neoplasms
1
Adenocarcinoma, Follicular
1
Interventions
Whole-Body Irradiation
4
Sulindac
4
Peripheral Blood Stem Cell Transplantation
4
Methotrexate
4
fludarabine phosphate
3
Selenium
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
Cetuximab
3
Biopsy
3
Tacrolimus
2
Sirolimus
2
Radiotherapy, Intensity-Modulated
2
Polymerase Chain Reaction
2
Mycophenolic Acid
2
Melphalan
2
Gene Expression Profiling
2
Etoposide
2
Darbepoetin alfa
2
Cyclosporine
2
Cyclophosphamide
2
Cisplatin
2
Busulfan
2
Aspirin
2
Aminolevulinic Acid
2
Albumin-Bound Paclitaxel
2
vandetanib
1
ruxolitinib
1
polyphenon E
1
perillyl alcohol
1
peginterferon alfa-2b
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Precancerous Conditions
×
tanespimycin
×
Clear all
No trials found.